James M. Hollands

926 total citations
28 papers, 652 citations indexed

About

James M. Hollands is a scholar working on Cardiology and Cardiovascular Medicine, Critical Care and Intensive Care Medicine and Pulmonary and Respiratory Medicine. According to data from OpenAlex, James M. Hollands has authored 28 papers receiving a total of 652 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Cardiology and Cardiovascular Medicine, 5 papers in Critical Care and Intensive Care Medicine and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in James M. Hollands's work include Clinical Nutrition and Gastroenterology (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). James M. Hollands is often cited by papers focused on Clinical Nutrition and Gastroenterology (5 papers), Atrial Fibrillation Management and Outcomes (5 papers) and Venous Thromboembolism Diagnosis and Management (5 papers). James M. Hollands collaborates with scholars based in United States and United Kingdom. James M. Hollands's co-authors include Scott T. Micek, Lee P. Skrupky, Eli N. Deal, Brian J. Barnes, Marin H. Kollef, Jennifer R. Smith, Heather Arnold, Angela L. Bingham, Joshua A. Doherty and Jamie M. Rosini and has published in prestigious journals such as CHEST Journal, Critical Care Medicine and Critical Reviews in Oncology/Hematology.

In The Last Decade

James M. Hollands

28 papers receiving 632 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
James M. Hollands United States 14 167 161 161 119 108 28 652
Sofia Medvedev United States 13 143 0.9× 154 1.0× 75 0.5× 63 0.5× 191 1.8× 18 640
Glen Brown Canada 16 176 1.1× 107 0.7× 73 0.5× 53 0.4× 97 0.9× 46 706
Cesar Alaniz United States 13 173 1.0× 75 0.5× 68 0.4× 57 0.5× 152 1.4× 37 585
Gretchen L. Sacha United States 15 302 1.8× 76 0.5× 134 0.8× 153 1.3× 230 2.1× 53 641
Tania Ahuja United States 11 91 0.5× 166 1.0× 245 1.5× 37 0.3× 35 0.3× 59 585
Fabrizio Colombo Italy 11 82 0.5× 133 0.8× 110 0.7× 67 0.6× 67 0.6× 38 435
Jian Shou United States 17 225 1.3× 92 0.6× 38 0.2× 171 1.4× 210 1.9× 33 823
Hollis R. O’Neal United States 13 204 1.2× 89 0.6× 75 0.5× 125 1.1× 80 0.7× 35 560
K. Phillips Australia 15 95 0.6× 522 3.2× 36 0.2× 72 0.6× 233 2.2× 30 1.1k
Georg Delle Karth Austria 16 230 1.4× 602 3.7× 66 0.4× 66 0.6× 277 2.6× 31 1.0k

Countries citing papers authored by James M. Hollands

Since Specialization
Citations

This map shows the geographic impact of James M. Hollands's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James M. Hollands with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James M. Hollands more than expected).

Fields of papers citing papers by James M. Hollands

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James M. Hollands. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James M. Hollands. The network helps show where James M. Hollands may publish in the future.

Co-authorship network of co-authors of James M. Hollands

This figure shows the co-authorship network connecting the top 25 collaborators of James M. Hollands. A scholar is included among the top collaborators of James M. Hollands based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James M. Hollands. James M. Hollands is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hollands, James M., et al.. (2023). Prevalence and Value of Board Certification Among Pharmacy Practice Faculty in the United States. American Journal of Pharmaceutical Education. 88(1). 100623–100623. 1 indexed citations
2.
Nagy, Ahmed, et al.. (2022). 313: OPTIMAL ENERGY PROVISION EARLY IN ICU STAY FOR PATIENTS RECEIVING PARENTERAL NUTRITION. Critical Care Medicine. 51(1). 143–143. 1 indexed citations
3.
Bingham, Angela L., et al.. (2020). Advanced cardiac life support certification for student pharmacists improves simulated patient survival. Currents in Pharmacy Teaching and Learning. 12(8). 975–980. 12 indexed citations
4.
Hollands, James M., et al.. (2019). Student-Led Cardiopulmonary Resuscitation Education to Lay Providers Results in Successful Knowledge Acquisition and Skill Performance.. PubMed. 48(1). 18–21. 3 indexed citations
5.
Shah, Sunish, James M. Hollands, Laura Pontiggia, & Angela L. Bingham. (2019). Impact of the Time to Initiation of Parenteral Nutrition on Patient Outcomes in Critically Ill Adults. Nutrition and Metabolic Insights. 12. 1009589107–1009589107. 3 indexed citations
6.
7.
Cawley, Michael J., et al.. (2018). Performance and retention of basic life support skills improve with a peer-led training program. Currents in Pharmacy Teaching and Learning. 10(6). 744–749. 11 indexed citations
8.
Babiker, Hani M., Ali McBride, Michael Newton, et al.. (2018). Cardiotoxic effects of chemotherapy: A review of both cytotoxic and molecular targeted oncology therapies and their effect on the cardiovascular system. Critical Reviews in Oncology/Hematology. 126. 186–200. 78 indexed citations
9.
Hollands, James M., et al.. (2016). Do Patients With a Baseline Clinical Condition Warranting the Cautious Use of Parenteral Nutrition Develop Subsequent Metabolic Complications?. Nutrition in Clinical Practice. 32(3). 400–406. 3 indexed citations
10.
Arnold, Heather, James M. Hollands, Lee P. Skrupky, et al.. (2013). Prolonged Infusion Antibiotics for Suspected Gram-Negative Infections in the ICU: A Before-After Study. Annals of Pharmacotherapy. 47(2). 170–180. 41 indexed citations
11.
Hollands, James M., et al.. (2012). Role of New Drugs for Management of Atrial Fibrillation. Annals of Pharmacotherapy. 46(12). 1656–1670. 2 indexed citations
12.
Harrison, Chris, et al.. (2011). Student perceptions of the progress test in two settings and the implications for test deployment. Advances in Health Sciences Education. 17(4). 573–583. 28 indexed citations
13.
Deal, Eli N., et al.. (2011). Evaluation of therapeutic anticoagulation with enoxaparin and associated anti-Xa monitoring in patients with morbid obesity: a case series. Journal of Thrombosis and Thrombolysis. 32(2). 188–194. 33 indexed citations
14.
Skrupky, Lee P., Jennifer R. Smith, Eli N. Deal, et al.. (2010). Comparison of Bivalirudin and Argatroban for the Management of Heparin‐Induced Thrombocytopenia. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 30(12). 1229–1238. 45 indexed citations
15.
Barnes, Brian J. & James M. Hollands. (2010). Drug-induced arrhythmias. Critical Care Medicine. 38(6 Suppl). S188–S197. 45 indexed citations
16.
Arnold, Heather, James M. Hollands, Lee P. Skrupky, & Scott T. Micek. (2009). Optimizing Sustained Use of Sedation in Mechanically Ventilated Patients: Focus on Safety. Current Drug Safety. 5(1). 6–12. 18 indexed citations
17.
Deal, Eli N., James M. Hollands, Garrett E. Schramm, & Scott T. Micek. (2008). Role of corticosteroids in the management of acute respiratory distress syndrome. Clinical Therapeutics. 30(5). 787–799. 25 indexed citations
18.
19.
Rosini, Jamie M., Lee P. Skrupky, Joshua A. Doherty, et al.. (2007). Analysis of 30-Day Mortality for Clostridium difficile -Associated Disease in the ICU Setting. CHEST Journal. 132(2). 418–424. 117 indexed citations
20.
Hollands, James M., et al.. (2006). Safety of high-dose iron sucrose infusion in hospitalized patients with chronic kidney disease. American Journal of Health-System Pharmacy. 63(8). 731–734. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sofia Medvedev Breakdown of academic impact, for papers by Glen Brown Breakdown of academic impact, for papers by Cesar Alaniz Breakdown of academic impact, for papers by Gretchen L. Sacha Breakdown of academic impact, for papers by Tania Ahuja Breakdown of academic impact, for papers by Fabrizio Colombo Breakdown of academic impact, for papers by Jian Shou Breakdown of academic impact, for papers by Hollis R. O’Neal Breakdown of academic impact, for papers by K. Phillips Breakdown of academic impact, for papers by Georg Delle Karth
Rankless by CCL
2026